Abstract:ABSTRACT Cryptococcus neoformans is a life-threatening fungal pathogen that is a causative agent for pulmonary infection and meningoencephalitis in both immunocompetent and immunodeficient individuals. Recent studies have elucidated the important function of the target of rapamycin (TOR) signaling pathway in the modulation of C. neoformans virulence factor production and pathogenicity in animal infection models. Herein, we discovered that Ypk1, a critical component of the TOR signaling pathway, acts as a critical modulator in fungal pathogenicity through post-translational modifications (PTMs). Mass spectrometry analysis revealed that Ypk1 is subject to protein acetylation at lysines 315 and 502, and both sites are located within kinase functional domains. Inhibition of the C. neoformans TOR pathway by rapamycin activates the deacetylation process for Ypk1. The YPK1Q strain, a hyper-acetylation of Ypk1, exhibited increased sensitivity to rapamycin, decreased capsule formation ability, reduced starvation tolerance, and diminished fungal pathogenicity, indicating that deacetylation of Ypk1 is crucial for responding to stress. Deacetylase inhibition assays have shown that sirtuin family proteins are critical to the Ypk1 deacetylation mechanism. After screening deacetylase mutants, we found that Dac1 and Dac7 directly interact with Ypk1 to facilitate the deacetylation modification process via a protein–protein interaction. These findings provide new insights into the molecular basis for regulating the TORC–Ypk1 axis and demonstrate an important function of protein acetylation in modulating fungal pathogenicity. IMPORTANCE Cryptococcus neoformans is an important opportunistic fungal pathogen in humans. While there are currently few effective antifungal treatments, the absence of novel molecular targets in fungal pathogenicity hinders the development of new drugs. There is increasing evidence that protein post-translational modifications (PTMs) can modulate the pathogenicity of fungi. In this study, we discovered that the pathogenicity of C. neoformans was significantly impacted by the dynamic acetylation changes of Ypk1, the immediate downstream target of the TOR complex. We discovered that Ypk1 is acetylated at lysines 315 and 502, both of which are within kinase functional domains. Deacetylation of Ypk1 is necessary for formation of the capsule structure, the response to the TOR pathway inhibitor rapamycin, nutrient utilization, and host infection. We also demonstrate that the sirtuin protein family is involved in the Ypk1 deacetylation mechanism. We anticipate that the sirtuin–Ypk1 regulation axis could be used as a potential target for the development of antifungal medications.

Advances in TOR pathway in Candida albicans

TORC1 Signaling in Fungi: from Yeasts to Filamentous Fungi

Multiple roles and diverse regulation of the Ras/cAMP/protein kinase A pathway in Candida albicans

Advances in the MAPK signaling pathway of Candida albicans

The Candida Albicans TOR-Activating GTPases Gtr1 and Rhb1 Coregulate Starvation Responses and Biofilm Formation

Regulatory Function of Phosphorylation and Ubiquitination on The TORC1 Signaling Pathway

Phosphate is the Third Nutrient Monitored by TOR in Candida Albicans and Provides a Target for Fungal-Specific Indirect TOR Inhibition

Advances in the Mechanisms of Amino Acid Signaling in mTORC1 Pathway

Nutritional control via Tor signaling in Saccharomyces cerevisiae

Integration of the Tricarboxylic Acid (tca) Cycle with Camp Signaling and Sfl2 Pathways in the Regulation of Co2 Sensing and Hyphal Development in Candida Albicans

Global regulatory roles of the cAMP/PKA pathway revealed by phenotypic, transcriptomic and phosphoproteomic analyses in a null mutant of the PKA catalytic subunit in Candida albicans: Global roles of the cAMP/PKA pathway in C. albicans

The mammalian target of rapamycin pathway and its role in molecular nutrition regulation.

The TORC2-Dependent Signaling Network in the Yeast Saccharomyces cerevisiae

PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress.

Hyper-Synergistic Antifungal Activity of Rapamycin and Peptide-Like Compounds against Candida albicans Orthogonally via Tor1 Kinase

Sirtulin–Ypk1 regulation axis governs the TOR signaling pathway and fungal pathogenicity in Cryptococcus neoformans

The transcription factors of phenotypic transition signal pathways in Candida albicans

Target of Rapamycin (TOR) Regulates Growth in Response to Nutritional Signals

Progress in mTOR study

THE mTOR SIGNALING PATHWAY AND THE REGULATION OF CELL GROWTH

Global regulatory roles of the cAMP/PKA pathway revealed by phenotypic, transcriptomic and phosphoproteomic analyses in a null mutant of the PKA catalytic subunit in Candida albicans